Moreover, IL-33/ST2 signaling promotes accumulation and function of Treg cells in inflamed tissues and accelerates malignant progression in solid tumors12,15–17, but its contribution to AML development remains unknown. This evidence concerns the gene IL33 and acute myeloid leukemia.